Expression of chemokines and gelatinase B in sympathetic ophthalmia

Eye

Volumn 21, Issue 5, 2007, Pages 649-657

  Abu El Asrar, A M ^a   Struyf, S ^b   Van den Broeck, C ^c   Van Damme, J ^b   Opdenakker, G ^b   Geboes, K ^d   Kestelyn, P ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD3 ANTIBODY; CD68 ANTIGEN; GELATINASE B; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYCLONAL ANTIBODY; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHOROID CAPILLARY LAYER; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENUCLEATION; EPITHELIOID CELL; FEMALE; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MONOCYTE; ORBIT GRANULOMA; PATHOGENESIS; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; SYMPATHETIC OPHTHALMIA; T LYMPHOCYTE;

EID: 34248368077     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702342     Document Type: Article

References (62)

1. Fuchs E. Über sympathisierende Entzündung (nebst Bemerkungen über serose traumatische Iritis). Albrecht von Graefes Arch Ophthalmol 1905; 61: 365-456.
2. Chan C-C, Nussenblatt RB, Fujikawa LS, Palestine AG, Stevens Jr G, Parver LM et al. Sympathetic ophthalmia: Immunopathological findings. Ophthalmology 1986; 93: 690-695.
3. Chan C-C, Ben Ezra D, Hsu S-M, Palestine AG, Nussenblatt RB. Granulomas in sympathetic ophthalmia and sarcoidosis: Immunohistochemical study. Arch Ophthalmol 1985; 103: 198-202.
4. Shah DN, Piacentini MA, Burnier Jr MN, McLean IW, Nussenblatt RB, Chan C-C. Inflammatory cellular kinetics in sympathetic ophthalmia: A study of 29 traumatized (exciting) eyes. Ocul Immunol Inflam 1993; 1 255-262.
5. Struyf S, Proost P, Van Damme J. Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 2003; 81: 1-44.
6. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: A tuner and amplifier of immune functions. Trends Immunol 2001; 22: 571-579.
7. Proost P, Wuyts A, Van Damme J. Human monocyte chemotactic proteins-2 and -3: Structural and functional comparison with MCP-1. J Leukoc Biol 1996; 59: 67-74.
8. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y et al. Defects of B cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382: 635-638.
9. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996; 184: 1101-1109.
10. Bleul CC, Schultze JL, Springer TA. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med 1998; 187: 753-762.
11. Mcleod SJ, Li AHY, Lee RL, Burgess AE, Gold MR. The Rap GTPases regulate B cell migration toward the chemokine stromal cell-derived factor-1 (CXCL12): Potential role for Rap2 in promoting B cell migration. J Immunol 2002; 169: 1365-1371.
12. + T cell activation. J Immunol 2000; 164 5010-5014.
13. Matthys P, Hatse S, Vermeire K, Wuyts A, Bridger G, Henson GW et al. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J Immunol 2001; 167: 4686-4692.
14. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991; 5: 2145-2154.
15. Opdenakker G, Van Damme J. Cytokines and proteases in invasive processes: Molecular similarities between inflammation and cancer. Cytokine 1992; 4: 251-258.
16. Paemen L, Martens E, Masure S, Opdenakker G. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity. Eur J Biochem 1995; 234: 759-765.
17. Auw-Haedrich C, Loeffler KU, Witschel H. Sympathetic ophthalmia: An immunohistochemical study of four cases. Ger J Ophthalmol 1996; 5: 98-103.
18. Lim W-K, Chee S-P, Sng I, Nussenblatt RB, Chan C-C. Immunopathology of progressive subretinal fibrosis: A variant of sympathetic ophthalmia. Am J Ophthalmol 2004; 138: 475-477.
19. Dunlop AA, Cree IA, Hague S, Luthert PJ, Lightman S. Multifocal choroiditis: Clinicopathologic correlation. Arch Ophthalmol 1998; 116: 801-803.
20. Liversidge J, Forrester JV. Experimental autoimmune uveitis (EAU): immuno-phenotypic analysis of inflammatory cells in chorioretinal lesions. Curr Eye Res 1988; 7: 1231-1241.
21. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998; 102: 938-946.
22. Armengol MP, Juan M, Lucas-Martin A, Fernândez-Figueras MT, Jaraquemada D, Gallart T et al. Thyroid autoimmune disease. Demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am J Pathol 2001; 159: 861-872.
23. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is B cell dependent. J Immunol 2001; 167: 4710-4718.
24. Panayi GS. B cells: A fundamental role in the pathogenesis of rheumatoid arthritis? Rheumatology (Oxford) 2005; 44(Suppl 2): Ii3-ii7.
25. Kerr MA. The structure and function of human IgA. Biochem J 1990; 271: 285-296.
26. Kaplan S, Hyman K, Brooks R, Wakai M, Hashimoto S, Furie R et al. Monoclonal IgM, IgG, and IgA human rheumatoid factors produced by snynovial tissue-derived, EBV-transformed B cell lines. Clin Immunol Immunopathol 1993; 66: 18-25.
27. Pillemer SR, Reynolds WJ, Yoon SJ, Perera M, Newkirk M, Klein M. IgA related disorders in rheumatoid arthritis. J Rheumatol 1987; 14 880-886.
28. Otten HG, Daha MR, van Laar JM, de Rooy HH, Breedveld FC. Subclass distribution and size of human IgA rheumatoid factor at mucosal and nonmucosal sites. Arthritis Rheum 1991; 34: 831-839.
29. Jorgensen C, Legouffe MC, Bologna C, Brochier J, Sany J. IgA isotype rheumatoid factor in rheumatoid arthritis: Clinical implications. Clin Exp Rheumatol 1996; 14: 301-304.
30. Bharadwaj A, Aggarwal A, Misra R. Clinical relevance of IgA rheumatoid factor (RF) in children with juvenile rheumatoid arthritis. Rheumatol Int 1999; 19: 47-49.
31. Matin K, Salam A, Akhter J, Hanada N, Senpuku H. Role of stromal-cell derived factor-1 in the development of autoimmune disease in non-obese diabetic mice. Immunology 2002; 107: 222-231.
32. Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A et al. Role of the chemokine stromal cell-derived factor-1 in autoantibody production and nephritis in murine lupus. J Immunol 2003; 170: 3392-3400.
33. Blades MC, Manzo A, Ingegnoli F, Taylor PR, Panayi GS, Irjala H et al. Stromal cell-drived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCLD mice. J Immunol 2002; 168: 4308-4317.
34. + T cell migration within synovial tissue. Arthritis Rheum 2003; 48: 2472-2482.
35. + T cell accumulation in rheumatoid arthritis synovium. J Immunol 2000; 165: 6590-6598.
36. Blades MC, Ingegnoli F, Wheller SK, Manzo A, Wahid S, Panayi GS et al. Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID mice. Arthritis Rheum 2002; 46: 824-836.
37. Fang I-M, Yang C-H, Lin C-P, Yang C-M, Chen M-S. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res 2004; 78: 1043-1055.
38. Kunkel SL, Chensue SW, Strieter RM, Lynch JP, Remick DG. Cellular and molecular aspects of granulomatous inflammation. Am J Respir Cell Mol Biol 1989; 1: 439-447.
39. Kreipe H, Radzun HJ, Rudolph P, Barth J, Hansmann ML, Heidorn K et al. Multinucleated giant cells generated in vitro. Terminally differentiated macrophages with down-regulated C-Fms expression. Am J Pathol 1988; 130: 232-243.
40. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992; 148: 2423-2428.
41. Flory CM, Jones ML, Warren JS. Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1. Lab Invest 1993; 69: 396-104.
42. He W, Casadevall A, Lee SC, Goldman DL. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary Cryptococcosis. Infect Immun 2003; 71: 930-936.
43. Kim J, Chae C. Expression of monocyte chemoattractant protein-1 but not interleukin-8 in granulomatous lesions in lymph nodes from pigs with naturally occurring postweaning multisystemic wasting syndrome. Vet Pathol 2003; 40: 181-186.
44. Iyonaga K, Suga M, Ichiyasu H, Yamamoto T, Hiraga Y, Ando M. Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 165-172.
45. Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: Immunochemical and in-situ hybridization analyses. Exp Eye Res 1997; 65: 781-789.
46. Holtkamp GM, Devos AF, Peek R, Kijlstra A. Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta2 (TGF-β2) by human retinal pigment epithelial cells. Clin Exp Immunol 1999; 118: 35-40.
47. Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV. Control of chemokine production at the blood-retina barrier. Immunology 2000; 101: 426-433.
48. Keino H, Takeuchi M, Kezuka T, Yamakawa N, Tsukahara R, Usui M. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice. Graefe's Arch Clin Exp Ophthalmol 2003; 241: 111-115.
49. Adamus G, Manczak M, Machnicki M. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE. Invest Ophthalmol Vis Sci 2001; 42: 2894-2903.
50. Crane IJ, McKillop-Smith S, Wallace CA, Lamont GR, Forrester JV. Expression of the chemokines MIP-1α, MC P-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2001; 42: 1547-1552.
51. Verma MJ, Lloyd A, Rager H, Strieter R, Kunkel S, Taub D et al. Chemokines in acute anterior uveitis. Curr Eye Res 1997; 16: 1202-1208.
52. El-Shabrawi Y, Christen WG, Foster CT Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1β, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis. Curr Eye Res 2000; 20: 211-214.
53. Abu El-Asrar AM, Struyf S, Descamps FJ, Al-Obeidan SA, Proost P. Van Damme J et al. Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am J Ophthalmol 2004; 138: 401-411.
54. Hibbs MS. Expression of 92 kDa phagocyte gelatinase by inflammatory and connective tissue cells. Matrix Suppl 1992; 1: 51-57.
55. Price NM Gilman RH, Uddin J, Recavarren S, Friedland JS. Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-α-dependent monocyte networks. J Immunol 2003; 171: 5579-5586.
56. Grillet B, Dequeker J, Paemen L. Van Damme B, Opdenakker G. Gelatinase B in chronic synovitis: Immumolocalization with a monoclonal antibody. Br J Rheumatol 1997; 36: 744-747.
57. Gonzâlez AA, Segura AM, Horiba K, Qian S, Yu Z-X, Stetler-Stevenson W et al. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: An immunohistochemical study. Hum Pathol 2002; 33: 1158-1164.
58. Opdenakker G. Van Damme J. Cytokine-regulated proteases in autoimmune diseases. Immunol Today 1994; 15: 103-107.
59. Van den Steen PE, Proost P, Grillet B, Brand DD, Kang AH, Van Damme J et al. Cleavage of denatured natural collagen II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 2002; 16: 379-389.
60. Descamps FJ, Van den Steen PE, Martens E, Ballaux F, Geboes K, Opdenakker G. Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin. FASEB J 2003; 17: 887-889.
61. Murphy G, Cookett MI, Ward RV, Docherty AJP. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 92 and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 1991; 277 277-279.
62. El-Shabrawi S, Walch A, Hermann J, Egger G, Foster CS. Inhibition of MMP-dependent chemotaxis and amelioration of experimental autoimmune uveitis with a selective metalloproteinase-2 and -9 inhibitor. J Neuroimmunol 2004; 155: 13-20.